Blend Labs, Inc. (NYSE:BLND – Get Free Report) insider Brian Kneafsey sold 30,000 shares of the stock in a transaction on Tuesday, January 14th. The stock was sold at an average price of $3.41, for a total transaction of $102,300.00. Following the completion of the sale, the insider now owns 836,759 shares in the company, valued at $2,853,348.19. The trade was a 3.46 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Brian Kneafsey also recently made the following trade(s):
- On Tuesday, January 7th, Brian Kneafsey sold 30,000 shares of Blend Labs stock. The shares were sold at an average price of $3.73, for a total transaction of $111,900.00.
- On Tuesday, December 31st, Brian Kneafsey sold 30,000 shares of Blend Labs stock. The shares were sold at an average price of $4.27, for a total value of $128,100.00.
- On Tuesday, December 17th, Brian Kneafsey sold 30,000 shares of Blend Labs stock. The stock was sold at an average price of $5.05, for a total value of $151,500.00.
- On Tuesday, December 10th, Brian Kneafsey sold 30,000 shares of Blend Labs stock. The shares were sold at an average price of $5.12, for a total value of $153,600.00.
Blend Labs Price Performance
NYSE BLND traded down $0.12 during trading hours on Thursday, hitting $3.61. 2,127,914 shares of the company’s stock traded hands, compared to its average volume of 4,075,370. The firm’s 50-day moving average is $4.58 and its 200-day moving average is $3.80. The company has a market capitalization of $922.63 million, a PE ratio of -10.60 and a beta of 1.38. Blend Labs, Inc. has a 52-week low of $2.08 and a 52-week high of $5.53.
Hedge Funds Weigh In On Blend Labs
Analyst Ratings Changes
Several equities analysts have recently weighed in on BLND shares. Citizens Jmp raised shares of Blend Labs to a “strong-buy” rating in a report on Wednesday, December 18th. UBS Group increased their price target on Blend Labs from $3.00 to $4.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 23rd. Wells Fargo & Company boosted their price target on shares of Blend Labs from $4.50 to $6.50 and gave the stock an “overweight” rating in a report on Thursday, December 5th. JMP Securities started coverage on shares of Blend Labs in a research note on Wednesday, December 18th. They set an “outperform” rating and a $7.00 target price for the company. Finally, Keefe, Bruyette & Woods raised their price target on shares of Blend Labs from $3.25 to $3.85 and gave the company a “market perform” rating in a research note on Thursday, November 7th. Two equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $5.11.
Read Our Latest Analysis on Blend Labs
About Blend Labs
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Featured Articles
- Five stocks we like better than Blend Labs
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- The Significance of Brokerage Rankings in Stock Selection
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Find and Profitably Trade Stocks at 52-Week Lows
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.